| |
| Issue |
Title |
| |
| No 23 (2024) |
On the issue of pleiotropic effects of febuxostat |
Abstract
PDF (Rus)
|
|
I. B. Bashkova, I. V. Madyanov |
| |
| No 5 (2024) |
Urate-lowering therapy for gout: Difficulties in goal achieving the and ways to overcome |
Abstract
PDF (Rus)
|
|
I. G. Krasivina, L. N. Dolgova, N. V. Dolgov |
| |
| No 5 (2024) |
Adherence to osteoarthritis therapy: problems and solutions |
Abstract
PDF (Rus)
|
|
Yu. S. Filatova, O. V. Zheltkevich, O. N. Solodchuk, L. A. Kramskaya |
| |
| No 5 (2024) |
A case of granulomatos is with polyangiitis (Wegener’s) after a patient’s suffering from a new coronavirus infection COVID-19 |
Abstract
PDF (Rus)
|
|
M. A. Balaganskaya, S. N. Galkina, A. V. Teteneva, E. A. Starovoytova, N. A. Kirillova, T. V. Sorokina, N. Yu. Kolesnik, K. S. Sergeeva, T. A. Zagromova, S. V. Fedosenko |
| |
| No 5 (2024) |
Hereditary human diseases with skeletal pathology – molecular pathogenesis and clinical characteristics |
Abstract
PDF (Rus)
|
|
D. I. Valeeva, R. I. Khusainova, L. N. Khusainova, A. V. Tyurin |
| |
| No 10 (2023) |
Realities of modern urate-reducing therapy for gout |
Abstract
PDF (Rus)
|
|
I. G. Krasivina, L. N. Dolgova, N. V. Dolgov, D. Yu. Bakhvalova |
| |
| No 10 (2023) |
Potential for sustaining remission in ankylosing spondylitis patients upon netakimab discontinuation |
Abstract
PDF (Rus)
|
|
S. A. Lapshina, A. R. Garaeva, Z. N. Gabdullina, E. V. Sukhorukova, D. I. Abdulganieva |
| |
| No 10 (2023) |
Predictors of repeated and first-time low-energy fractures in patients with rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
P. S. Kovalenko, I. S. Dydykina, P. S. Postnikova, S. I. Glukhova |
| |
| No 3 (2023) |
Difficulties in the treatment of primary osteoarthritis |
Abstract
PDF (Rus)
|
|
I. B. Bashkova, E. I. Busalaeva |
| |
| No 3 (2023) |
Evaluation of the effectiveness of ketorolac or external use in the complex treatment of osteoarthritis of the knee joints |
Abstract
PDF (Rus)
|
|
M. S. Svetlova |
| |
| No 3 (2023) |
Glycosaminoglycan-peptide complex: data on the mechanism of action and efficacy in osteoarthritis |
Abstract
PDF (Rus)
|
|
N. V. Chichasova, A. M. Lila |
| |
| No 3 (2023) |
Advantages of zoledronic acid in the therapy of osteoporosis in real clinical practice |
Abstract
PDF (Rus)
|
|
L. E. Sivordova, Yu. V. Polyakova, E. V. Papichev, Yu. R. Akhverdyan, B. V. Zavodovskii |
| |
| No 21 (2022) |
Clinical efficiency and safety of innovative synovial fluid prosthesis in the treatment of gonarthritis |
Abstract
PDF (Rus)
|
|
L. E. Sivordova, J. V. Polyakova, E. V. Papichev, Y. R. Akhverdyan, B. V. Zavodovsky |
| |
| No 21 (2022) |
Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: results of 10 years of use |
Abstract
PDF (Rus)
|
|
N. V. Chichasova, A. M. Lila |
| |
| No 21 (2022) |
Osteoarthritis of the joints of the hands. Review of clinical recommendations |
Abstract
PDF (Rus)
|
|
Yu. S. Filatova, M. V. Ilyin |
| |
| No 21 (2022) |
Phenotypic manifestations of connective tissue dysplasia in individuals with joint hypermobility |
Abstract
PDF (Rus)
|
|
K. E. Akhiiarova, Kh. Kh. Gantseva, R. I. Khusainova, A. V. Tyurin |
| |
| No 21 (2022) |
Zoledronic acid for osteoporosis and associated low-energy fractures |
Abstract
PDF (Rus)
|
|
S. S. Rodionova, A. F. Kolondaev, A. N. Torgashin, I. A. Solomyannik |
| |
| No 14 (2022) |
Febuxostat as an effective drug of choice for urate-lowering therapy for gout (case report) |
Abstract
PDF (Rus)
|
|
A. B. Bashkova, I. V. Madyanov |
| |
| No 14 (2022) |
The value of undenatured collagen for the normalization of the function of the cartilaginous tissue of the joints |
Abstract
PDF (Rus)
|
|
I. S. Dydykina, P. S. Kovalenko, A. A. Kovalenko, A. V. Aboleshina |
| |
| No 11 (2022) |
Colchicine for the treatment of COVID-19: short path from theory to practice |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, O. V. Zheliabina |
| |
| No 11 (2022) |
The optimal way to fill the deficiency of essential substances for the well-being of the joints |
Abstract
PDF (Rus)
|
|
I. S. Dydykina, P. S. Kovalenko, A. A. Aboleshina, A. A. Kovalenko |
| |
| No 11 (2022) |
Interleukin-6 inhibitors: from the therapy of immuno-inflammatory rheumatic diseases to use in COVID-19 |
Abstract
PDF (Rus)
|
|
N. V. Muravyeva, B. S. Belov |
| |
| No 11 (2022) |
Evaluation of the tolerability of zoledronic acid preparations for parenteral administration |
Abstract
PDF (Rus)
|
|
I. A. Shafieva, S. V. Bulgakova, A. V. Shafieva |
| |
| No 2 (2022) |
Local injection therapy: the use of hyaluronic acid in osteoarthritis and other joint diseases |
Abstract
PDF (Rus)
|
|
I. S. Dydykina, P. S. Kovalenko, A. V. Aboleshina, A. A. Kovalenko |
| |
| No 2 (2022) |
Post covid syndrome and rheumatic diseases: focus on rheumatoid arthritis (own data) |
Abstract
PDF (Rus)
|
|
E. S. Aronova, B. S. Belov, G. I. Gridneva |
| |
| No 2 (2022) |
Рain syndrome in the shoulder joint. Clinical significance of bioactive concentrate of small seafish in real clinical practice |
Abstract
PDF (Rus)
|
|
L. E. Sivordova, Yu. V. Polyakova, E. V. Papichev, Yu. R. Akhverdyan, B. V. Zavodovskii |
| |
| No 12 (2021) |
Modern facilities of pharmacological correction of hyperuricemia in rheumatic diseases: management of difficult clinical cases |
Abstract
PDF (Rus)
|
|
L. E. Sivordova, Yu. V. Polyakova, E. V. Papichev, Yu. R. Akhverdyan, B. V. Zavodovskii |
| |
| No 12 (2021) |
Menopausal osteoporosis in the practice of a gynecologist |
Abstract
PDF (Rus)
|
|
I. V. Kuznetsova, R. A. Chilova |
| |
| No 10 (2021) |
The use of biosimilars as a new approach to the treatment of rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
N. V. Chichasova, A. M. Lila |
| |
| No 10 (2021) |
Therapeutic niche of hyaluronic acid derivatives in osteoarthritis |
Abstract
PDF (Rus)
|
|
I. G. Krasivina, L. N. Dolgova, N. V. Dolgov |
| |
| No 10 (2021) |
Antirheumatic drugs and COVID-19: frustrations and hopes |
Abstract
PDF (Rus)
|
|
E. S. Aronova, B. S. Belov |
| |
| No 10 (2021) |
Rheumatoid arthritis of menopause: there are more questions than answers |
Abstract
PDF (Rus)
|
|
A. Z. Khashukoeva, A. V. Naumov, A. D. Meshkov, O. V. Rassokhina |
| |
| No 10 (2021) |
Colchicine for gout |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, M. N. Chikina, A. M. Novikova |
| |
| No 4 (2021) |
Local anti-inflammatory therapy for osteoarthritis with high comorbidity |
Abstract
PDF (Rus)
|
|
I. G. Krasivina, L. N. Dolgova, N. V. Dolgov |
| |
| No 4 (2021) |
Rheumatic polymyalgia: clinic, diagnosis, principles of therapy (to help the primary care physician) |
Abstract
PDF (Rus)
|
|
M. S. Svetlova |
| |
| No 2 (2021) |
Use of Janus kinase inhibitors in the treatment of immunoinflammatory rheumatic diseases: safety issues |
Abstract
PDF (Rus)
|
|
B. S. Belov, N. V. Muravyeva, G. M. Tarasova, M. M. Baranova |
| |
| No 2 (2021) |
Patients with osteoarthritis of the knee: management in the outpatient setting |
Abstract
PDF (Rus)
|
|
Yu. S. Filatova, I. N. Solovyov |
| |
| No 19 (2020) |
Modern paradigm of treatment of hyperuricemia and gout in comorbid patients with the development of cardio-vascular pathology |
Abstract
PDF (Rus)
|
|
V. I. Mazurov, I. B. Belyaeva, M. S. Petrova, R. A. Bashkinov |
| |
| No 19 (2020) |
Management tactics for patients with osteoarthritis: a joint view of a rheumatologist and an orthopedic traumatologist |
Abstract
PDF (Rus)
|
|
Yu. S. Filatova, I. N. Solovyov |
| |
| No 19 (2020) |
Regarding the problem of viral hepatitis reactivation in rheumatic diseases: risks and curation issues |
Abstract
PDF (Rus)
|
|
B. S. Belov, N. V. Muravyeva, G. M. Tarasova |
| |
| No 19 (2020) |
Experience with the use of chondroitin sulfate for pain in the back |
Abstract
PDF (Rus)
|
|
O. A. Shavlovskaya, Yu. S. Prokofyeva |
| |
| No 11 (2020) |
Modern principles for the diagnosis and treatment of postmenopausal osteoporosis: a focus on bisphosphonates |
Abstract
PDF (Rus)
|
|
I. B. Belyaeva, V. I. Mazurov, A. L. Chudinov |
| |
| No 11 (2020) |
Clinical discussion: gout therapy in a comorbid patient |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, A. M. Novikova |
| |
| No 11 (2020) |
Strategy for the management of osteoarthritis in multimorbid patients: the balance of effectiveness and safety while choosing drug therapy |
Abstract
PDF (Rus)
|
|
K. Yu. Belova, A. V. Nazarova |
| |
| 1 - 44 of 44 Items |
|
